Crossmark

CD45RO+TILs: cellular biomarkers for larynx squamous cell carcinoma outcome

Crossref DOI link: https://doi.org/10.1016/j.bjorl.2022.09.007

Published Print: 2022-11

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Mohammadi, Yousef https://orcid.org/0000-0002-9840-1552
Ahmadvand, Simin https://orcid.org/0000-0002-1560-0012
Mirtalebi, Maryam https://orcid.org/0000-0003-3206-5055
Ashraf, Mohammad Javad https://orcid.org/0000-0002-4987-8477
Khademi, Bijan https://orcid.org/0000-0002-8303-6126
Ghaderi, Abbas https://orcid.org/0000-0003-0849-3375
Funding

Funding for this research was provided by:

Shiraz University of Medical Sciences (99-01-01-22530)

Shiraz Institute for Cancer Research, Shiraz University of Medical Sciences (ICR-100-508)
License Information

Text and Data Mining valid from 2022-11-01

Text and Data Mining valid from 2022-11-01

Version of Record valid from 2022-10-11
More Information

This article is maintained by: Elsevier

Article Title: CD45RO+TILs: cellular biomarkers for larynx squamous cell carcinoma outcome

Journal Title: Brazilian Journal of Otorhinolaryngology

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.bjorl.2022.09.007

Content Type: article

Copyright: © 2022 Published by Elsevier Editora Ltda. on behalf of Associação Brasileira de Otorrinolaringologia e Cirurgia Cérvico-Facial.